子宫畸形对IVF/ICSI冻融胚胎移植妊娠及新生儿结局的影响
该回顾性队列研究纳入2008年7月至2019年8月行IVF/ICSI首次冻融胚胎移植的411例子宫畸形女性和14936例正常子宫女性,经倾向性评分匹配比较生殖结局。双角子宫组活产率显著低于对照组(24.4% vs 34.8%,OR 0.61),纵隔子宫组流产率升高(23.5% vs 13.0%,OR 2.05)且活产率降低(29.4% vs 42.2%,OR 0.57),单角子宫组结局与对照组无显著差异。
要点
- 双角子宫活产率显著低于对照(24.4% vs 34.8%,OR 0.61,95%CI 0.37-1.00)。
- 纵隔子宫流产率升高、活产率降低(OR 2.05和0.57)。
- 单角子宫临床妊娠率及活产率与对照无显著差异。
核心结论
- 与正常子宫患者相比,子宫畸形女性生殖结局更差。
- 双角子宫与更差的新生儿结局相关,包括更高的早产率和更低的出生体重。
- 纵隔子宫与更差的生育结局相关,包括更高的流产率和更低的活产率。
研究设计与样本
- 回顾性队列研究,纳入2008年7月至2019年8月行IVF/ICSI首次冻融胚胎移植的411例子宫畸形女性和14936例正常子宫女性。
- 通过三个倾向性评分匹配比较(双角子宫、纵隔子宫和单角子宫组分别与无子宫畸形的相应对照组)研究生殖结局。
- 亚组分析独立比较双角子宫、双角双颈子宫和纵隔子宫手术前后的妊娠及新生儿结局。
主要发现
- 双角子宫组活产率显著低于匹配对照组(24.4% vs 34.8%,OR 0.61,95%CI 0.37-1.00,P=0.048)。
- 双角子宫组流产率(29.0% vs 18.1%,OR 1.85,95%CI 0.82-4.19,P=0.135)和早产率(22.6% vs 9.9%,OR 2.64,95%CI 1.07-6.52,P=0.063)高于对照但未达统计学显著。
- 双角子宫组较双角子宫对照组 gestational age 更低、剖宫产率更高、出生体重更低。
- 纵隔子宫组临床妊娠率与对照相当(43.3% vs 49.9%,OR 0.77,95%CI 0.57-1.04,P=0.091),流产率升高(23.5% vs 13.0%,OR 2.05,95%CI 1.18-3.58,P=0.010),活产率降低(29.4% vs 42.2%,OR 0.57,95%CI 0.41-0.79,P=0.001)。
- 单角子宫组临床妊娠率(36.8% vs 42.3%,OR 0.80,95%CI 0.52-1.21,P=0.287)和活产率(29.8% vs 33.1%,OR 0.86,95%CI 0.55-1.34,P=0.502)有低于对照的趋势;流产率16.7% vs 16.6%(OR 1.01,95%CI 0.41-2.47,P=0.989),早产率9.5% vs 11.4%(OR 0.82,95%CI 0.27-2.51,P=1)。
临床怎么用
- 作者认为,与正常子宫患者相比,子宫畸形女性生殖结局更差。
- 作者认为,妊娠合并子宫畸形的女性需按高危妊娠管理,并接受适当的产科评估随访。
局限性
- 本研究为单中心回顾性研究,新生儿数据提取自父母问卷。
- 子宫纵隔类型和手术方法的信息呈现不充分,细节有限。
- 子宫畸形患者中出生缺陷婴儿数和双胎妊娠数相对较少,限制了研究效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the impact of uterine malformations on reproductive and neonatal outcomes of IVF/ICSI-frozen embryo transfer? SUMMARY ANSWER: Unification defective uteri are associated with poorer neonatal outcomes including higher preterm delivery rate and lower birthweight, and septate uteri are associated with worse fertility outcomes including higher miscarriage and lower live birth rates (LBRs). WHAT IS KNOWN ALREADY: Several studies have investigated the negative effects of uterine malformations on pregnancy outcomes. However, an all-round and definitive conclusion has not been reached yet owing to the relatively low incidence of the disease and the heterogeneity of study populations, especially among women undergoing ART. STUDY DESIGN, SIZE, DURATION: This was a retrospective cohort study including 411 women with congenital uterine anomalies and 14 936 women with a normal uterus who underwent first frozen-thawed embryo transfer cycles of IVF/ICSI from July 2008 to August 2019. We compared reproductive outcomes. PARTICIPANTS/MATERIALS, SETTING, METHODS: Reproductive outcomes of women with uterine malformations were studied through three propensity score-matched comparisons (patients with bicorporeal uterus, septate uterus and hemi-uterus [bicorporeal, septate and hemi-uterus groups, respectively] along with corresponding control groups without uterine malformations). We also compared pregnancy and neonatal outcomes, and performed subgroup analysis addressing didelphus, bicornuate uteri and septate uteri before and after surgery independently. MAIN RESULTS AND THE ROLE OF CHANCE: Compared to the matched control group, women with a bicorporeal uterus had a significantly lower LBR (24.4% versus 34.8%, odds ratio (OR) 0.61 [95% CI: 0.37, 1.00], P = 0.048). The incidence of miscarriage and preterm delivery was higher but not statistically significant (29.0% versus 18.1%, OR 1.85 [95% CI: 0.82, 4.19], P = 0.135; 22.6% versus 9.9%, OR 2.64 [95% CI: 1.07, 6.52], P = 0.063, respectively). In addition, the bicorporeal group had a significantly lower gestational age, higher caesarean rate and lower birthweight than bicorporeal control. Women with a septate uterus had comparable clinical pregnancy rates to controls (43.3% versus 49.9%, OR 0.77 [95% CI: 0.57, 1.04], P = 0.091), increased miscarriage rates (23.5% versus 13.0%, OR 2.05 [95% CI: 1.18, 3.58], P = 0.010) and lower LBRs (29.4% versus 42.2%, OR 0.57 [95% CI: 0.41, 0.79], P = 0.001). In both singleton and twins pregnancies, pregnancy and neonatal outcomes were comparable between women with a septate uterus and control. Women with a hemi-uterus had a tendency for lower clinical pregnancy rate (36.8% versus 42.3%, OR 0.80 [95% CI: 0.52, 1.21], P = 0.287) and LBR (29.8% versus 33.1%, OR 0.86 [95% CI: 0.55, 1.34], P = 0.502), compared to women without malformations. The incidences of miscarriage and preterm delivery, respectively, were 16.7% versus 16.6% (OR 1.01 [95% CI: 0.41, 2.47], P = 0.989), and 9.5% versus 11.4% (OR 0.82 [95% CI: 0.27, 2.51], P = 1) in women with a hemi-uterus as compared to control. LIMITATIONS, REASONS FOR CAUTION: This was a single-centre, retrospective study in which neonatal data were extracted from parental questionnaires. The information on uteri septum type and surgery methods was poorly presented, with limited detail. In patients with uterine malformations, the number of babies with birth defects and twin pregnancies was relatively small, limiting the power of the study. WIDER IMPLICATIONS OF THE FINDINGS: Compared to patients with a normal uterus, women with uterine malformation have poorer reproductive outcomes. Pregnant women with a uterine anomaly need to be managed as high-risk pregnancies and followed with appropriate obstetric review. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the National Ministry of Technology (2018YFC1003000), the Elite Team Project of Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine (JY201801), Shanghai Sailing Program (21YF1423200) and the Fundamental Research Program Funding of Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine (JYZZ117). B.W.M. is supported by an NHMRC Investigatorgrant (GNT1176437). B.W.M. reports consultancy (with stock options) for ObsEva. B.W.M. has received research funding from Ferring and Merck. The authors declare no other competing interests. TRIAL REGISTRATION NUMBER: N/A.
引用
- Qiu J, Du T, Chen C, et al. Impact of uterine malformations on pregnancy and neonatal outcomes of IVF/ICSI-frozen embryo transfer. Hum Reprod. 2022. PMID: 35048124. doi:10.1093/humrep/deac003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。